Publication: Thymic tumors and outcomes after radiotherapy
dc.contributor.author | Sarıhan, Süreyya | |
dc.contributor.author | Bayram, Ahmet Sami | |
dc.contributor.author | Gebitekin, Cengiz | |
dc.contributor.author | Yerci, Ömer | |
dc.contributor.author | Özkan, Lütfi | |
dc.contributor.buuauthor | SARIHAN, SÜREYYA | |
dc.contributor.buuauthor | BAYRAM, AHMET SAMİ | |
dc.contributor.buuauthor | GEBİTEKİN, CENGİZ | |
dc.contributor.buuauthor | YERCİ, ÖMER | |
dc.contributor.buuauthor | Özkan, Lütfi | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi Anabilim Dalı | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı | |
dc.contributor.orcid | 0000-0003-4816-5798 | |
dc.contributor.orcid | 0000-0003-0684-0900 | |
dc.contributor.researcherid | AAE-1069-2022 | |
dc.contributor.researcherid | ABB-7580-2020 | |
dc.contributor.researcherid | AAH-4970-2021 | |
dc.contributor.researcherid | EIS-5114-2022 | |
dc.contributor.researcherid | JGQ-9310-2023 | |
dc.date.accessioned | 2024-11-07T08:17:00Z | |
dc.date.available | 2024-11-07T08:17:00Z | |
dc.date.issued | 2013-01-01 | |
dc.description.abstract | OBJECTIVESWe evaluated the results of treatment in patients with thymic tumors treated with postoperative adjuvant radiotherapy.METHODSEighteen patients were treated median 5400 cGy radiotherapy between 1995-2010. Diagnosis of patients were thymoma (n=10), thymic carcinoma (n=7), thymic neuroendocrin carcinoma (n=1). RO resection was made on 12 of them. According to prognostic stratification with Masaoka stage and WHO classification, there were 5 good, 7 moderate, and 6 poor risk patients. Survival was calculated from diagnosis.RESULTSA total of 33% patients were recurred median 29.5 months with 34 months follow-up. Local control, median overall and disease-free survival for all patients were 77%, 113 months, and 105 months. Local control for good, moderate, poor risk groups were found 100%, 71%, 50%. There were significant differences survival rates for Masaoka stage, RO resection, and prognostic groups.CONCLUSIONPrognostic risk classification was found to be better predictive in terms of local control and survival. | |
dc.identifier.doi | 10.5505/tjoncol.2013.904 | |
dc.identifier.endpage | 66 | |
dc.identifier.issn | 1300-7467 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 59 | |
dc.identifier.uri | https://doi.org/10.5505/tjoncol.2013.904 | |
dc.identifier.uri | https://onkder.org/pdf/pdf_TOD_857.pdf | |
dc.identifier.uri | https://hdl.handle.net/11452/47546 | |
dc.identifier.volume | 28 | |
dc.indexed.wos | WOS.ESCI | |
dc.language.iso | en | |
dc.publisher | Kare Yayın | |
dc.relation.journal | Türk Onkoloji Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Thymic tumor | |
dc.subject | Adjuvant radiotherapy | |
dc.subject | Local control | |
dc.subject | Prognostic group | |
dc.subject | Survival | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Oncology | |
dc.title | Thymic tumors and outcomes after radiotherapy | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 07b16629-e65c-40b0-b11d-825ad7943570 | |
relation.isAuthorOfPublication | bdb7801d-f0bc-4abc-af2c-5bf7df23fbd5 | |
relation.isAuthorOfPublication | 029ec57f-2451-4282-8110-61c87cd6a41d | |
relation.isAuthorOfPublication | 559e3ec8-742a-46d4-bf58-8bb138ca553d | |
relation.isAuthorOfPublication.latestForDiscovery | 07b16629-e65c-40b0-b11d-825ad7943570 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Sarıhan_vd_2013.pdf
- Size:
- 1.51 MB
- Format:
- Adobe Portable Document Format